Pharma Focus Asia

Biovian Unveils Plan for US$54 million (€50 million) Manufacturing Facility Investment in Turku, Finland

Introduction:

Biovian has unveiled plans to make an investment of US$54 million (€50 million) in expanding its manufacturing facility in Turku, Finland.

Features:

The new facility, which covers an area of 6,400 square metres (69,000 square feet), will feature cutting-edge machinery and advanced technologies to facilitate the entire process of creating, manufacturing, and testing Advanced Therapy Medicinal Products (ATMP), including therapies like adenoviral and adeno-associated viral (AAV) treatments.

When combined with current manufacturing site, the new facility will expand the overall area to 11,500 square metres (123,800 square feet).

Additionally, the facility will include specialised cleanroom sections, ranging from Class A to D, dedicated to the production of bulk drug substances and the final manufacturing of drug products.

The new space serves as a valuable addition to the existing manufacturing facilities in the region, providing with the capability to embark on larger-scale viral vector and microbial protein projects.

As the new facility becomes operational, the existing capacity will be repurposed into innovative microbial protein suites. 

This expansion will not only enhance the capacity for viral vector production but also provide increased capabilities and adaptability in microbial protein manufacturing.

The new facility is projected to become fully operational by 2025 and generate around 100 employment opportunities within the region.

Specifications:

Name    Biovian
Type      New Construction
Budget   US$54 million (€50 million)
Year       2025

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024